Shanghai Fosun Pharmaceutical (Group) Co Ltd (SFOSF)
1.695
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
Shanghai Fosun Pharmaceutical Total Liabilities (Quarterly): 7.899B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.899B |
| December 31, 2023 | 8.020B |
| September 30, 2023 | 7.509B |
| June 30, 2023 | 7.816B |
| June 30, 2023 | 7.816B |
| March 31, 2023 | 7.604B |
| December 31, 2022 | 7.690B |
| September 30, 2022 | 7.171B |
| June 30, 2022 | 7.620B |
| June 30, 2022 | 7.620B |
| March 31, 2022 | 7.552B |
| December 31, 2021 | 7.048B |
| September 30, 2021 | 6.474B |
| June 30, 2021 | 6.401B |
| June 30, 2021 | 6.401B |
| March 31, 2021 | 6.020B |
| December 31, 2020 | 5.771B |
| September 30, 2020 | 6.016B |
| June 30, 2020 | 5.685B |
| June 30, 2020 | 5.685B |
| March 31, 2020 | 5.344B |
| December 31, 2019 | 5.276B |
| September 30, 2019 | 5.701B |
| June 30, 2019 | 5.688B |
| June 30, 2019 | 5.688B |
| Date | Value |
|---|---|
| March 31, 2019 | 5.708B |
| December 31, 2018 | 5.417B |
| September 30, 2018 | 5.160B |
| June 30, 2018 | 5.390B |
| June 30, 2018 | 5.390B |
| March 31, 2018 | 5.223B |
| December 31, 2017 | 4.937B |
| September 30, 2017 | 4.090B |
| June 30, 2017 | 3.412B |
| June 30, 2017 | 3.412B |
| March 31, 2017 | 3.101B |
| December 31, 2016 | 2.666B |
| September 30, 2016 | 2.943B |
| June 30, 2016 | 2.880B |
| June 30, 2016 | 2.880B |
| March 31, 2016 | 2.830B |
| December 31, 2015 | 2.701B |
| September 30, 2015 | 2.747B |
| June 30, 2015 | 2.654B |
| June 30, 2015 | 2.654B |
| March 31, 2015 | 2.484B |
| December 31, 2014 | 2.617B |
| September 30, 2014 | 2.415B |
| June 30, 2014 | 2.169B |
| June 30, 2014 | 2.169B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.276B
Minimum
Dec 2019
8.020B
Maximum
Dec 2023
6.701B
Average
6.474B
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.635B |
| CASI Pharmaceuticals Inc | 42.54M |
| Zai Lab Ltd | 226.27M |
| Gracell Biotechnologies Inc (DELISTED) | 36.85M |
| Adagene Inc | 45.17M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.98B |
| Shareholders Equity (Quarterly) | 6.513B |
| Debt to Equity Ratio | 0.7098 |
| Current Ratio | 1.007 |
| Net Debt Paydown Yield | -1.55% |